Discover the detailed record of transactions filed by Sofinnova Venture Partners X, L.P.. Director active across 3 companies, notably Vera Therapeutics, Inc.. Aggregated, 7 disclosures have been logged. Total volume traded: €3.5m. The latest transaction was disclosed on 10 February 2022 — Acquisition. Regulator: SEC (Form 4). The full history is free.